Nestlé offers free teleconsultation to parents affected by milk recall

Upgrade to High-Speed Internet for only ₱1499/month!

Enjoy up to 100 Mbps fiber broadband, perfect for browsing, streaming, and gaming.

Visit Suniway.ph to learn

January 19, 2026 | 12:00am

MANILA, Philippines —  Nestlé Philippines Inc. is offering free teleconsultation services to parents whose infants and kids were affected by its recalled formula milk products, as the Food and Drug Administration (FDA) reviews complaints of health-related concerns regarding the concerned items.

Nestlé Philippines said it is working closely with the FDA following the state regulator’s advisory on reported symptoms that were potentially associated with the multinational firm’s recalled batches of NAN Optipro and NANKID Optipro milk products.

“Our foremost concern is for the families who are worried about the health of their children. We understand the concern and disruption this may be causing parents and caregivers and we are here to support them,” the company said in a statement yesterday.

“Our priority is to address their immediate needs and provide assistance,” the company added.

Nestlé Philippines said it is now offering parents with free access to teleconsultation services with health care professionals for medical-related questions. The company added that it has “significantly” expanded its consumer care teams to respond “promptly” to customers’ inquiries.

“We are offering direct support, including product replacement for recalled products,” it said.

“We are also working closely with our retail partners to ensure an efficient return and exchange process nationwide,” it added.

On Jan. 16, the FDA issued an advisory informing the public that it has received 25 reports associated with Nestlé’s recalled products, 18 of which involved health concerns observed by parents following the consumption of the infant formula products.

The FDA added that the reported symptoms included vomiting, diarrhea, abdominal pain and other conditions, some of which, it pointed out, required medical attention.

The FDA said it is reviewing the complaints to determine the appropriate regulatory action.

“Each report is evaluated and - when necessary –– the FDA coordinates with relevant agencies and offices to ensure proper handling, verification and resolution of the reported concerns,” it said.

Meanwhile, Nestlé Philippines explained that there is currently no established food safety threshold for cereulide toxin in infant formula products. In the absence of such regulatory standard, the company acted on scientific recommendations to avoid exposure to the toxin and to prioritize the well-being of infants and children.

“Determining whether any reported health issue is related to the affected product requires clear clinical evidence, which includes ruling out other possible causes such as common seasonal infections,” Nestlé Philippines said.

“We are working with the FDA to ensure that all reports are carefully reviewed and appropriately resolved,” it added.

The Philippines is among more than 50 countries covered by a global voluntary recall of certain Nestlé infant formula products.

Nestlé issued a recall advisory after detecting that some batches may have been contaminated with cereulide, a toxin produced by the bacteria Bacillus cereus, which can cause foodborne illness. According to the advisory, the possible source of contamination was arachidonic acid oil supplied to Nestlé.

There are 35 batches of NAN Optipro milk products and four batches of NANKID Optipro 3+ that were voluntarily recalled in the Philippines..